Using computer models, researchers discover melanopsin pigment in the eye is more sensitive to light than rhodopsin pigment.
Researchers have successfully activated the brain's opioid receptors using optogenetics.
New research reveals the key chemical process that corrects for potential visual errors in low-light conditions. Understanding this fundamental step could lead to new treatments for visual deficits, or might one day boost normal night vision to new levels.
Researchers have discovered a new type of photoreceptor that is about 50 times more efficient at capturing light than the rhodopsin in the human eye.
Researchers have made novel discoveries about how the eye processes light on both cellular and molecular levels.
Researchers have developed a variant of the Mu opioid receptor which has several advantages for experimentation The variant can be grown in large quantities and is water soluble, allowing for experiments and applications which have previously been challenging.